EVIO Labs Executes Cannabis Testing License Agreement in Colorado
September 07 2017 - 10:50AM
InvestorsHub NewsWire
EVIO Labs Executes Cannabis Testing License Agreement in
Colorado
Bend, OR -- September 7, 2017 -- InvestorsHub NewsWire -- EVIO,
Inc. (OTCQB:
SGBYD) a leading provider of cannabis testing and advisory
services announced today that its cannabis testing division EVIO
Labs has entered into an agreement to license its brand and
cannabis technology in Colorado. Phytatech CO, LLC which has been a
licensed testing company since 2014, will now operate under the
EVIO Labs brand.
EVIO CEO Mr. William Waldrop stated, "As we continue our mission
to become the industrys largest cannabis testing company, with
operations in California, Oregon, Massachusetts, and Florida, EVIO
is honored to now offer its accredited testing services to
Colorado. The State of Colorado has continued to be an advocate and
leader in the cannabis industry, being the first state to offer
retail cannabis products, and the first to develop and enforce
testing requirements.
Phytatech CO, LLC was founded in 2014, and has been an industry
leader in Colorado as both a licensed medical and retail (adult
use) testing provider, servicing licensed cultivators and
manufacturers of infused products (MIPs).
Phytatech founder Robert Howland commented, Since the beginning
we have had the resources to build a strong foundation. As the
industry continues to mature we felt it important to engage a
company such as EVIO Labs who is committed to improving the
standards within the industry and provide us the resources to
broaden our reach to the entire cannabis community. From an
operational perspective in the short term, this will have little
change to our existing clients. Moreover, in partnership with EVIO
we seek to expand our overall service offerings to help our clients
improve the quality of their products to meet the continued growing
demand of the industry.
About EVIO
EVIO, Inc. is a life science company that provides accredited
analytical testing services and scientific research to the
regulated cannabis industry. The Companys EVIO Labs division
provides state-mandated ancillary services that dont directly
support the supply chain, but are in place to ensure the safety and
quality of the nation's cannabis supply. Learn more at www.eviolabs.com. The company can be reached
directly @ 1-888-544-EVIO.
Safe Harbor Statement
Any statements in this press release that are not statements of
historical fact may be considered to be forward-looking statements.
Statements may contain certain forward-looking statements
pertaining to future anticipated or projected plans, performance
and developments, as well as other statements relating to future
operations and results. Words such as "may," "will," "expect,"
"believe," "anticipate," "estimate," "intends," "goal,"
"objective," "seek," "attempt," or variations of these or similar
words, identify forward-looking statements. These forward-looking
statements by their nature are estimates of future results only and
involve substantial risks and uncertainties, including but not
limited to risks associated with the uncertainty of future
financial results, additional financing requirements, development
of new products, our ability to complete our product testing and
launch our product commercially, the acceptance of our product in
the marketplace, the uncertainty of the laws and regulations
relating to cannabis, the impact of competitive products or
pricing, technological changes, the effect of economic conditions
and other uncertainties detailed from time to time in our reports
filed with the Securities and Exchange Commission, available at
www.sec.gov or www.eviolabs.com
Investor Relations:
investors@eviolabs.com